PDF(Pubmed)
Abstract：
The coronavirus disease 2019 (COVID-19) pandemic has resulted in large-scale devastation. Reports of COVID-19 in patients with compromised immunity are available in the literature. The compromised immunity could be due to multiple factors like drug induced as in organ transplant patients, diabetes, HIV, etc. Post-transplant patients with compromised immunity due to immune suppression are vulnerable to many infections (tuberculosis, hepatitis B and C, etc.). Herein a case of an Indian male with a kidney transplant is presented who had concurrent infections of pulmonary and extrapulmonary tuberculosis due to Mycobacterium tuberculosis, hepatitis C virus, and severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). A detailed history with laboratory workup was done to establish the diagnosis and a prompt treatment was initiated for the three infections. To the best knowledge of the author, no such case has ever been reported in the medical literature to date. The management of this rare case is highlighted in this present write-up.
摘要：
2019年冠状病毒病(COVID-19)大流行导致了大规模的破坏。关于免疫功能受损患者的COVID-19报告可在文献中获得。免疫力受损可能是由于多种因素，例如在器官移植患者中诱导的药物，糖尿病,艾滋病毒,等。由于免疫抑制而导致免疫力低下的移植后患者容易受到许多感染（结核病，乙型肝炎和丙型肝炎，等。).本文介绍了一名印度男性进行肾脏移植的病例，该病例因结核分枝杆菌同时感染肺和肺外结核，丙型肝炎病毒，和严重急性呼吸道综合症冠状病毒2（SARS-CoV-2）。进行了详细的病史和实验室检查以确定诊断，并对这三种感染进行了迅速治疗。据作者所知，迄今为止，医学文献中从未报道过此类病例。这种罕见的情况下的管理突出了在这个目前的文章。
